John F. Heerdink, Jr.’s Post

Curious about DMEK EndoGlide? Tune into this #EversightAcademy webinar with Asim V. Farooq, MD, for a case presentation and discussion at 7:30 p.m. ET Thursday, Dec. 5. #YouChangeLives

We're happy to share some insights from our recent #AACR poster presentation. Our CSO, Michael Newman, and CEO, Jeffrey Meckler, discuss Key findings video from Indaptus Therapeutics (NASDAQ: INDP): "Our poster not only confirmed the robust data from our preclinical animal studies, but also demonstrated similar success with #human #immunecells in the lab. There has been a long-standing misconception that bacteria can only activate the innate side of the immune system—our results clearly show activation of the #adaptive #immunesystem as well. Excitingly, our studies also revealed additive or synergistic effects when combined with the established cancer treatment, Interleukin 2 (IL-2). This suggests additional potential for our Decoy technology in combination therapies. Watch the discussion to learn more about how these findings are fueling our mission to revolutionize cancer treatment. #IndaptusTherapeutics #biotechnology #cancerresearch #Immunotherapy #Decoy20 $INDP #MichaelNewmann #JeffreyMeckler

Countdown to ADLM! We are excited to see you July 28 to August 1 in Chicago, IL for ADLM! From simple, rapid point-of-care (POC) tests to complex assays analyzed in a laboratory setting, We welcome the opportunity to discuss your molecular or immunodiagnostic workflow needs and how Cytiva can help you achieve your goals. Stop by booth #3868 to say Hello 😁 #pointofcare #magneticbeads #diagnostics #lyo #moleculardiagnostics #immunodiagnostics

Springer Healthcare's official partnership with #ASCO is one of my favourite things about working here. Official ASCO content + Springer-led expert commentary is one of the things our learners value about our accredited programs. AND it means both Springer Nature and ASCO can co-market to reach both our audiences #CME #IME #NSCLC #oncology #meded #medicaleducation #independentmedicaleducation #SpringerHealthcareIME

See you at our Booth 16157 and let’s discuss Hummingbirds approach: The integrated analysis of tumor and immune system biomarkers from blood!

Missed the live session on *The origin-adjusted approach for biomarker quantification by LC–MS*? Don’t worry! The webinar recording is now available. Learn how this powerful approach can streamline biomarker workflows for your team! Watch now >>> https://hubs.ly/Q02XW3Hr0

In the premiere episode of #ConversationswithDrKohli, Dr. Deepak L. Bhatt, MD, MPH, MBA and I explore whether Sotagliflozin is just another SGLT2 inhibitor or a cut above the rest? Tune in for #NewScience YT: https://lnkd.in/gRAk4TUm

❗️ New results from a 5-year follow-up of KEYNOTE-177 have been published, offering data on the lasting durability of pembrolizumab for metastatic #colorectal cancer. 🔎 Learn how #pembrolizumab remains a standard of care for this disease state:

The audience of the #MultipleMyeloma Hub’s recent symposium enjoyed a dynamic Q&A session to conclude the presentations from our speakers on current and future perspectives for #bispecific antibodies. “How might a reduced dosing schedule of teclistamab impact patients' experience and quality of life?” “When sequencing bispecifics, would you sequence one immediately after the other or do something else in between?” “What is the rationale for the administration of alnuctamab via an intravenous route rather than subcutaneous?” https://loom.ly/l-19w64 #myeloma #mmsm

It will be a very useful and great webinar with my dearest friend Tugba S.. You can share this link with your colleagues or friends who want to join the webinar: https://lnkd.in/eK_JtZC7